Andrea Gobbo, Vittorio Fasulo, Roberto Contieri, Alessandro Uleri, Pier Paolo Avolio, Nicola Frego, Giovanni Lughezzani, Cesare Saitta, Gianluigi Taverna, Matteo Zanoni, Stefano Mancon, Piergiuseppe Colombo, Marina Valeri, Alberto Saita, Massimo Lazzeri, Nicolò M Buffi, Rodolfo Hurle, Paolo Casale
BACKGROUND: T1 high-grade (HG) non-muscle invasive bladder cancer (NMIBC) has a significant risk of recurrence and progression, and the European Association of Urology recommends a second transurethral resection of the bladder (ReTUR). Stage at ReTUR has been shown to be a reliable predictor of survival, therefore, we sought to assess clinical and pathological predictors associated with the persistence of T1 at ReTUR in our retrospective multicentric cohort. METHODS: This is a retrospective multicentric study of T1 HG patients at transurethral resection of the bladder (TURB) who underwent subsequent ReTUR...
June 21, 2023: Urologia